Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation Associated With”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02168920
What this trial is testing

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT00748098
What this trial is testing

Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance

Who this might be right for
Restless Legs SyndromeRestless Legs Syndrome (RLS)
XenoPort, Inc. 136
Not applicableStudy completedNCT03032887
What this trial is testing

Reducing Visitors- and Personnel-associated Infection Risk on Perinatal Care Station

Who this might be right for
Hygiene
Martin-Luther-Universität Halle-Wittenberg 300
Not applicableLooking for participantsNCT05908214
What this trial is testing

The Application of Wide Pulse High Frequency Neuromuscular Electrical Stimulation in Disorders Associated With Motoneuron Hyperexcitability

Who this might be right for
StrokeCrampRestless Legs Syndrome+1 more
University of Lausanne 110
Testing effectiveness (Phase 2)Looking for participantsNCT06803823
What this trial is testing

ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

Who this might be right for
Agitation Associated With Alzheimer's Disease Dementia
Ono Pharmaceutical Co., Ltd. 90
Not applicableUnknownNCT05573711
What this trial is testing

Restless Legs Syndrome in People With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis OpticaRestless Legs Syndrome
Dokuz Eylul University 30
Testing effectiveness (Phase 2)Study completedNCT00505804
What this trial is testing

A Comparison of Dexmedetomidine and Haloperidol in Patients With Intensive Care Unit (ICU)-Associated Agitation and Delirium

Who this might be right for
DeliriumAgitationVentilator Weaning+2 more
Austin Health 20
Not applicableNot Yet RecruitingNCT06495957
What this trial is testing

Electroacupuncture for the Treatment of Agitated Symptoms of Alzheimer's Disease

Who this might be right for
Agitation Associated With Alzheimer's DementiaAlzheimer's Dementia
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 224
Large-scale testing (Phase 3)Study completedNCT03548584
What this trial is testing

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Alzheimer's DementiaAlzheimer Dementia
Otsuka Pharmaceutical Development & Commercialization, Inc. 345
Not applicableTemporarily pausedNCT03513549
What this trial is testing

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Who this might be right for
Agitation,Psychomotor
Alexza Pharmaceuticals, Inc. 10,000
Large-scale testing (Phase 3)Ended earlyNCT05665088
What this trial is testing

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Who this might be right for
AgitationDementia
BioXcel Therapeutics Inc 13
Large-scale testing (Phase 3)Looking for participantsNCT06937229
What this trial is testing

Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Who this might be right for
Alzheimer DiseaseAgitation
Bristol-Myers Squibb 650
Testing effectiveness (Phase 2)Ended earlyNCT05276830
What this trial is testing

An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia

Who this might be right for
AgitationDementia
BioXcel Therapeutics Inc 5
Large-scale testing (Phase 3)Study completedNCT01862640
What this trial is testing

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 433
Large-scale testing (Phase 3)UnknownNCT05803642
What this trial is testing

Olanzapine in Patients With Acute Agitation

Who this might be right for
Acute Agitation
Qilu Pharmaceutical Co., Ltd. 318
Large-scale testing (Phase 3)Study completedNCT05271552
What this trial is testing

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)

Who this might be right for
AgitationDementia
BioXcel Therapeutics Inc 151
Large-scale testing (Phase 3)Study completedNCT00991276
What this trial is testing

Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance

Who this might be right for
Restless Legs Syndrome
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 85
Testing effectiveness (Phase 2)WithdrawnNCT05313386
What this trial is testing

Study of BXCL501 In Agitation Associated With Delirium in ICU Patients

Who this might be right for
AgitationDelirium
BioXcel Therapeutics Inc
Large-scale testing (Phase 3)Looking for participantsNCT07284472
What this trial is testing

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Who this might be right for
Agitation Associated With Alzheimer's Disease Dementia
Exciva GmbH 300
Large-scale testing (Phase 3)Study completedNCT03594123
What this trial is testing

A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 259
Next Page